Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| 1,1-Dimethylethyl N-[(3R)-1-[(2-cyanophenyl)methyl]-3-piperidinyl]carbamate | An impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. CAS No. 1353254-15-5. Pack Sizes: 100 mg. Product ID: B1370-425896. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| 2-[[3, 4-Dihydro-3-methyl-2, 4-dioxo-6-[ (3R)-3-piperidinylamino]-1 (2H)-pyrimidinyl]methyl]benzonitrile | An impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. CAS No. 2089611-85-6. Pack Sizes: 100 mg. Product ID: B1370-425895. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (2'R,2S,cis)-Saxagliptin | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. CAS No. 1564265-93-5. Pack Sizes: 2.5 mg. Product ID: B0016-007240. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (2R)-Vildagliptin | (2R)-Vildagliptin is an R-enantiomer of Vildagliptin, which is a dipeptidyl peptidase-4 (DPP-4) inhibitor used as an anti-hyperglycemic agent and an anti-diabetic drug. Group: Pharmaceutical. CAS No. 1036959-27-9. Pack Sizes: 20 mg. Product ID: B0020-461928. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Deoxy Saxagliptin | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. CAS No. 361441-98-7. Pack Sizes: 2.5 mg. Product ID: B0016-007241. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 4-((2-Hydroxyethoxy)carbonyl)benzoic acid | 4-((2-Hydroxyethoxy)carbonyl)benzoic acid, an essential pharmaceutical intermediate widely utilized for synthesizing dipeptidyl peptidase-4 (DPP-4) inhibitors, possesses potential anti-cancer properties with its pronounced efficacy in chronic myeloid leukemia (CML) and other cancer treatments. Plausible and encouraging observations in cancer research elucidate its immense promise as a therapeutic agent. Group: Pharmaceutical. CAS No. 1137-99-1. Pack Sizes: 100 mg. Product ID: B2699-223434. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acetyl 1-L-leucyL-L-arginine | Acetyl 1-L-leucyL-L-arginine is a lactone compound isolated from the Bacterium sp. BMG520-yF2. Acetyl 1-L-leucyL-L-arginine has the activity of inhibiting dipeptidyl aminopeptidase ?. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00009. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-Saxagliptin | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. CAS No. 709031-43-6. Pack Sizes: 25 mg. Product ID: B1370-149516. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Diprotin A | It is produced by the strain of Bacillus cereus BMF 657-RF1. It can inhibit Dipeptidyl amino peptidase IV and immune enhancement effect. Group: Pharmaceutical. CAS No. 90614-48-5. Pack Sizes: 500 mg. Product ID: BAT-010802. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Dha-OH | Fmoc-Dha-OH, a pivotal intermediate, is used for synthesizing a plethora of biologically active compounds encompassing antimicrobial peptides, dipeptidyl peptidase IV inhibitors, and enzyme inhibitors. Researchers have employed it to fabricate Fmoc-Dha-OH-derived peptidomimetics manifested by the impeding activity against a myriad of cancer cell lines. The said compound holds sheer potential for the design and development of novel pharmaceutical agents targeting numerous diseases. Group: Pharmaceutical. CAS No. 261522-33-2. Pack Sizes: 500 mg. Product ID: BAT-008269. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| H-Gly-Pro-Hyp-OH | A peptide inhibitor of dipeptidylpeptidase-IV (DPP-IV). Group: Pharmaceutical. CAS No. 2239-67-0. Pack Sizes: 500 mg. Product ID: BAT-015714. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin | Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Uses: The treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 668270-12-0. Pack Sizes: 2.5 g. Product ID: NP2669. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurities | Linagliptin Impurities hold a paramount position in the biomedical sector, instrumental for pharmaceutical research and quality control paradigms. These impurities facilitate the synthesis and evaluation of linagliptin, a pivotal type 2 diabetes treatment via dipeptidyl peptidase-4 enzyme inhibition, thereby assuring the drug's purity and therapeutic effectiveness. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 10 (S-Isomer) | a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 668270-11-9. Pack Sizes: 50 mg. Product ID: B0012-473823. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 7 Hydrochloride | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Pack Sizes: 50 mg. Product ID: B1370-449757. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity B | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 2138392-83-1. Pack Sizes: 10 mg. Product ID: B2694-473825. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity E | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 1446263-38-2. Pack Sizes: 10 mg. Product ID: B2694-242668. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Methyldimer | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 1418133-47-7. Pack Sizes: 10 mg. Product ID: B2694-473827. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin N-Acetyl Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1803079-49-3. Pack Sizes: 50 mg. Product ID: B0012-007233. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin N-Boc Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 668273-75-4. Pack Sizes: 50 mg. Product ID: B0012-007234. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-acetic acid-1-amino-3-adamantanol | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 1032564-18-3. Pack Sizes: 500 mg. Product ID: B2694-485169. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Acetyl Sitagliptin | N-Acetyl Sitagliptin is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1379666-94-0. Pack Sizes: 50 mg. Product ID: B2694-479646. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Cyano-N'-methyl-ethanimidamide | N-Cyano-N'-methyl-ethanimidamide has exhibited significant inhibitory activity against the dipeptidyl peptidase IV (DPP-4), which represents a pharmacological target for mitigating type 2 diabetes. In addition to this, the product has demonstrated antiviral potential against a diverse range of viral strains, among which the human immunodeficiency virus (HIV) is notable. The product's diverse clinical applications thus mandate in-depth investigation and analysis. Group: Pharmaceutical. CAS No. 56563-12-3. Pack Sizes: 5 g. Product ID: B1370-015289. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omarigliptin | Omarigliptin is a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor to be used as the treatment for type 2 diabetes. Group: Pharmaceutical. CAS No. 1226781-44-7. Pack Sizes: 25 mg. Product ID: B0084-462292. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide | (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide is an impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. CAS No. 1820685-30-0. Pack Sizes: 100 mg. Product ID: B1370-377540. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rac-Sitagliptin | Rac-Sitagliptin is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Uses: Dipeptidyl-peptidase iv inhibitors. Group: Pharmaceutical. CAS No. 823817-56-7. Pack Sizes: 50 mg. Product ID: B2693-211737. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rac-Vildagliptin Impurity F | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 1789703-36-1. Pack Sizes: 10 mg. Product ID: B2694-485167. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Cyclic Amidine Impurity | An impurity of saxagliptin.Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Group: Pharmaceutical. CAS No. 1350800-76-8. Pack Sizes: 5 mg. Product ID: B0016-479455. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Impurity 15 | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. CAS No. 1496712-39-0. Pack Sizes: 2.5 mg. Product ID: B0016-479445. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Impurity 7 | An impurity of saxagliptin.Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Group: Pharmaceutical. CAS No. 1350800-77-9. Pack Sizes: 2.5 mg. Product ID: B0016-479457. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Keto Impurity | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. Pack Sizes: 2.5 mg. Product ID: B0016-007239. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity A Phosphate | Sitagliptin EP Impurity A Phosphate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 823817-58-9. Pack Sizes: 100 mg. Product ID: B0017-479659. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity B | Sitagliptin EP Impurity B is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 486460-31-5. Pack Sizes: 25 mg. Product ID: B2694-479656. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity B Phosphate | Sitagliptin EP Impurity B Phosphate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1345822-87-8. Pack Sizes: 10 mg. Product ID: B2694-179047. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity C | Sitagliptin EP Impurity C is a impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 945261-48-3. Pack Sizes: 100 mg. Product ID: B2694-352408. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity C Phosphate | Sitagliptin EP Impurity C Phosphate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1345822-86-7. Pack Sizes: 30 mg. Product ID: B2694-174790. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin FP Impurity B | Sitagliptin FP Impurity B is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 2088771-61-1. Pack Sizes: 5 mg. Product ID: B2694-334170. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin FP Impurity E Hydrochloride | Sitagliptin EP Impurity E is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1204818-19-8. Pack Sizes: 1 g. Product ID: BAT-008056. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin Fumarate Adduct (Mixture of Diastereomers) | Sitagliptin Fumarate Adduct is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 2088771-60-0. Pack Sizes: 50 mg. Product ID: B2694-032361. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin Impurity 40 HCl | Sitagliptin Impurity 40 HCl is an impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1374985-05-3. Pack Sizes: 500 mg. Product ID: B2694-186710. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin phenylcrotonyl analog | Sitagliptin phenylcrotonyl analog is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1253056-18-6. Pack Sizes: 10 mg. Product ID: B0017-479654. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin Phosphate Monohydrate | Sitagliptin Phosphate Monohydrate is the phosphate salt form of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 654671-77-9. Pack Sizes: 100 g. Product ID: B2692-335254. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin styrylacetyl analog | Sitagliptin styrylacetyl analog is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1803026-58-5. Pack Sizes: 10 mg. Product ID: B0017-004064. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (S)-Sitagliptin N-Boc-Acid Impurity | (S)-Sitagliptin N-Boc-Acid Impurity is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 922178-94-7. Pack Sizes: 1 g. Product ID: BAT-008080. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Talabostat mesylate | Talabostat mesylate is the orally bioavailable mesylate salt of an amino boronic dipeptide with antineoplastic and hematopoiesis- stimulating activities. By cleaving N-terminal Xaa-Pro or Xaa-Ala residues, talabostat inhibits dipeptidyl peptidases, such as fibroblast activation protein (FAP), resulting in the stimulation of cytokine and chemokine production and specific T-cell immunity and T-cell- dependent activity. This agent may also stimulate the production of colony stimulating factors, such as granulocyte colony stimulating factor (G-CSF), resulting in the stimulation of hematopoiesis. Dipeptidyl peptidases are involved in the activation of polypeptide hormones and chemokines. Uses: For research used only. Group: Pharmaceutical. CAS No. 150080-09-4. Pack Sizes: 20 mg. Product ID: B0084-084554. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Teneligliptin | Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro. Group: Pharmaceutical. CAS No. 760937-92-6. Pack Sizes: 250 mg. Product ID: B0084-461910. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Teneligliptin HBr | Teneligliptin hydrobromide is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro. Group: Pharmaceutical. CAS No. 906093-29-6. Pack Sizes: 250 mg. Product ID: B0084-463677. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin | Glyptins are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. Aside from there use in type 2 diabetes, gliptins have positive cardiovascular and anti-inflammtatory effects. Antidiabetic. Uses: Dipeptidyl-peptidase iv inhibitors. Group: Pharmaceutical. CAS No. 274901-16-5. Pack Sizes: 5 g. Product ID: NP3358. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Impurities | Vildagliptin Impurities are critical in the pharmaceutical sector for assessing the purity of Vildagliptin, a medication widely used to manage type 2 diabetes by inhibiting dipeptidyl peptidase-4 (DPP-4). These impurities serve as benchmarks to ensure drug safety and efficacy during formulation and quality control processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Impurity 3 Trifluoroacetate | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 565453-41-0. Pack Sizes: 10 mg. Product ID: B2694-485165. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Impurity A | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 565453-39-6. Pack Sizes: 250 mg. Product ID: B2694-284718. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Impurity B | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 1036959-23-5. Pack Sizes: 500 mg. Product ID: B2694-485168. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Impurity E hydrochloride | An impurity of Vildagliptin, an anti-hyperglycemic agent of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. Group: Pharmaceutical. Pack Sizes: 25 mg. Product ID: B2694-074944. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Related Compound A | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 741657-02-3. Pack Sizes: 10 mg. Product ID: B2694-290136. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
